Stephen C Mccluski's Insider Trades & SAST Disclosures
Stephen C Mccluski's most recent trade in Monro Inc was a trade of 4,937 Restricted Stock Award done . Disclosure was reported to the exchange on Aug. 13, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Stephen C Mccluski.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Monro Inc | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Aug 2024 | 4,937 | 23,622 | - | 0 | Restricted Stock Award | |
| Monro Inc | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Aug 2023 | 3,749 | 18,685 | - | 0 | Restricted Stock Awards | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 19,597 | 19,597 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jun 2023 | 13,090 | 13,090 | - | - | Restricted Stock Unit | |
| Monro Inc | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Aug 2022 | 2,426 | 14,936 | - | 0 | Restricted Stock Awards | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2022 | 15,000 | 105,458 | - | - | Deferred Share Unit | |
| Monro Inc | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2021 | 2,351 | 12,510 | - | 0 | Restricted Stock Award | |
| Monro Inc | Stephen C. Mccluski | Director | Sale of securities on an exchange or to another person at price $ 58.65 per share. | 06 Aug 2021 | 10,000 | 10,159 (0%) | 0% | 58.7 | 586,528 | Common Stock |
| Monro Inc | Stephen C. Mccluski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Aug 2021 | 10,000 | 0 | - | - | Options (Right to Buy) | |
| Monro Inc | Stephen C. Mccluski | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 57.78 per share. | 06 Aug 2021 | 10,000 | 20,159 (0%) | 0% | 57.8 | 577,800 | Common Stock |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 44,000 | 44,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Jun 2021 | 15,000 | 90,458 | - | - | Deferred Share Unit | |
| Monro Inc | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 18 Aug 2020 | 2,575 | 10,159 | - | 0 | Restricted Stock Awards | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 50,000 | 50,000 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Stephen C. Mccluski | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2020 | 17,000 | 75,458 | - | - | Deferred Share Unit |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges